Agilent Technologies, Inc. (A) stock — is it a good business?

Agilent Technologies, Inc. (A) stock — is it a good business? — InspectStocks

How it makes money

Agilent CrossLab: laboratory supplies, equipment maintenance and repair, software, and automation42%
Life Sciences and Diagnostics Markets: instruments, clinical testing products, research supplies, and contract manufacturing for drug companies39%
Applied Markets: instruments and software for testing chemicals, food, the environment and advanced materials19%

Shares of revenue are estimates for nine months ended July 31, 2026, not figures from a filing.

Competes with

What it sells6

Infinity III liquid chromatography systems
Instruments that separate the substances in a liquid sample so a laboratory can identify and measure them.
8890B and 8860B gas chromatographs
Instruments that separate and measure substances that can be turned into gas, including chemicals in fuels and contaminants in food.
9500 triple-quadrupole inductively coupled plasma mass spectrometer
An instrument that measures very small amounts of metals and other elements, including in samples used in semiconductor manufacturing.

Show 3 more

Altura liquid chromatography columns
Replaceable tubes that separate substances inside a chromatography system, including in testing of protein-based and nucleic-acid medicines.
Dako Omnis pathology systems
Automated instruments and related supplies used by clinical laboratories to stain and examine tissue samples for cancer diagnosis.
Oligonucleotide contract manufacturing
Manufacturing of short DNA- or RNA-like drug ingredients for pharmaceutical customers, from development through commercial production.

Who buys it6

Pharmaceutical and biotechnology companies buy research instruments, testing supplies, diagnostic development services and contract manufacturing, mainly through Agilent’s direct sales teams.
Hospitals, medical centers and reference laboratories buy pathology instruments, reagents and other products for tissue-based cancer testing.
Clinical and molecular diagnostic laboratories buy instruments and reagents for patient testing, including genetic testing.

Show 3 more

Universities, government institutes and other research organizations buy laboratory instruments, supplies and services through direct sales, distributors and resellers.
Food, environmental and commercial testing laboratories buy instruments and supplies to test food, water, soil and other samples; public agencies also buy for monitoring and forensic work.
Chemical, advanced-materials and semiconductor manufacturers buy instruments and services to check materials, product quality and manufacturing processes.

What it stands on, and what could break it

What the business leans on

1Demand for some instruments depends on customers’ capital budgets, research spending and government funding.
2Some custom-designed parts are not readily available from alternative suppliers, and Agilent also uses outside companies for parts of manufacturing, warehousing and delivery.
3Sales and operations depend on meeting regulatory requirements for clinical and diagnostic products and on being able to ship products and source components across borders.

What could go wrong

1If pharmaceutical, academic, government or industrial customers reduce investment or research spending, demand for Agilent’s instruments and related products may fall.
2Failure to meet changing requirements for regulated diagnostic products can lead to product recalls, limits on sales or manufacturing, penalties, or loss of required approvals.
3Shortages of specialized parts, disruptions at outside manufacturers or delivery providers, or trade restrictions and tariffs can raise costs and delay products reaching customers.

Full financial statements →

About Agilent Technologies, Inc.

Agilent makes instruments that help laboratories identify and measure the chemicals, cells and other materials in samples. It also sells the supplies used with those instruments, maintains lab equipment, and provides software for collecting and managing test results. For drug companies, Agilent also makes ingredients used in some medicines and manufactures certain drug materials under contract.

Head office: Santa Clara, California
Founded: 1999
Employees: 18,200 (July 31, 2026, high)
Listed on: NYSE
Financial year ends: October 31

Built from Agilent Technologies, Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.

Keep exploring

The themes Agilent Technologies is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

The theme it is part of

Highest-graded in Diagnostics and Research

Graded A or B and worth $2B or more: A first, then the largest.

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

How it makes money

Agilent CrossLab: laboratory supplies, equipment maintenance and repair, software, and automation42%
Life Sciences and Diagnostics Markets: instruments, clinical testing products, research supplies, and contract manufacturing for drug companies39%
Applied Markets: instruments and software for testing chemicals, food, the environment and advanced materials19%

Shares of revenue are estimates for nine months ended July 31, 2026, not figures from a filing.

Competes with

What it sells6

Infinity III liquid chromatography systems
Instruments that separate the substances in a liquid sample so a laboratory can identify and measure them.
8890B and 8860B gas chromatographs
Instruments that separate and measure substances that can be turned into gas, including chemicals in fuels and contaminants in food.
9500 triple-quadrupole inductively coupled plasma mass spectrometer
An instrument that measures very small amounts of metals and other elements, including in samples used in semiconductor manufacturing.

Show 3 more

Altura liquid chromatography columns
Replaceable tubes that separate substances inside a chromatography system, including in testing of protein-based and nucleic-acid medicines.
Dako Omnis pathology systems
Automated instruments and related supplies used by clinical laboratories to stain and examine tissue samples for cancer diagnosis.
Oligonucleotide contract manufacturing
Manufacturing of short DNA- or RNA-like drug ingredients for pharmaceutical customers, from development through commercial production.

Who buys it6

Pharmaceutical and biotechnology companies buy research instruments, testing supplies, diagnostic development services and contract manufacturing, mainly through Agilent’s direct sales teams.
Hospitals, medical centers and reference laboratories buy pathology instruments, reagents and other products for tissue-based cancer testing.
Clinical and molecular diagnostic laboratories buy instruments and reagents for patient testing, including genetic testing.

Show 3 more

Universities, government institutes and other research organizations buy laboratory instruments, supplies and services through direct sales, distributors and resellers.
Food, environmental and commercial testing laboratories buy instruments and supplies to test food, water, soil and other samples; public agencies also buy for monitoring and forensic work.
Chemical, advanced-materials and semiconductor manufacturers buy instruments and services to check materials, product quality and manufacturing processes.

What it stands on, and what could break it

What the business leans on

1Demand for some instruments depends on customers’ capital budgets, research spending and government funding.
2Some custom-designed parts are not readily available from alternative suppliers, and Agilent also uses outside companies for parts of manufacturing, warehousing and delivery.
3Sales and operations depend on meeting regulatory requirements for clinical and diagnostic products and on being able to ship products and source components across borders.

What could go wrong

1If pharmaceutical, academic, government or industrial customers reduce investment or research spending, demand for Agilent’s instruments and related products may fall.
2Failure to meet changing requirements for regulated diagnostic products can lead to product recalls, limits on sales or manufacturing, penalties, or loss of required approvals.
3Shortages of specialized parts, disruptions at outside manufacturers or delivery providers, or trade restrictions and tariffs can raise costs and delay products reaching customers.

Full financial statements →

About Agilent Technologies, Inc.

Head office: Santa Clara, California
Founded: 1999
Employees: 18,200 (July 31, 2026, high)
Listed on: NYSE
Financial year ends: October 31

How it makes money

Competes with

What it sells6

Who buys it6

What it stands on, and what could break it

What the business leans on

What could go wrong

About Agilent Technologies, Inc.

Keep exploring

The theme it is part of

Highest-graded in Diagnostics and Research

Grade rose recently in Healthcare

How it makes money

Competes with

What it sells6

Who buys it6

What it stands on, and what could break it

What the business leans on

What could go wrong

About Agilent Technologies, Inc.

Agilent Technologies, Inc.

Keep exploring

The theme it is part of

Highest-graded in Diagnostics and Research

Grade rose recently in Healthcare

Lab tools & diagnostics

Growth & cash — 4 of 5

Business trend

Share price and grade over time

How it makes money

Competes with

What it sells6

Who buys it6

What it stands on, and what could break it

What the business leans on

What could go wrong

About Agilent Technologies, Inc.

Keep exploring

The theme it is part of

Highest-graded in Diagnostics and Research

Grade rose recently in Healthcare

How it makes money

Competes with

What it sells6

Who buys it6

What it stands on, and what could break it

What the business leans on

What could go wrong

About Agilent Technologies, Inc.

Agilent Technologies, Inc.

Past performance

Keep exploring

The theme it is part of

Highest-graded in Diagnostics and Research

Grade rose recently in Healthcare

Lab tools & diagnostics

Growth & cash — 4 of 5

Business trend

Share price and grade over time